Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 18 of 18 entries
View as:

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01742624 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06452212 Org: User:
Start: 07/10/24 End: 07/29/24 Due: 07/29/25

A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02034747 Org: User:
Start: 11/21/13 End: 11/07/15 Due: 11/07/16

A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01882322 Org: User:
Start: 01/30/13 End: 01/03/17 Due: 01/03/18

A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF

Phase: N/A Priority: Normal
NCT ID: NCT01839929 Org: User:
Start: 09/30/10 End: 02/28/13 Due: 02/28/14

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06902545 Org: User:
Start: 04/03/25 End: 07/31/30 Due: 07/31/31

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

Phase: N/A Priority: Normal
NCT ID: NCT06011954 Org: User:
Start: 11/01/23 End: 07/31/27 Due: 07/31/28

A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01316133 Org: User:
Start: 04/19/11 End: 04/08/16 Due: 04/08/17

Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03623217 Org: User:
Start: 02/24/15 End: 10/17/17 Due: 10/17/18

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

Phase: N/A Priority: Normal
NCT ID: NCT01747577 Org: User:
Start: 12/04/12 End: 10/24/13 Due: 10/24/14

A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02963103 Org: User:
Start: 05/31/10 End: 10/31/12 Due: 10/31/13

Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor

Phase: N/A Priority: Normal
NCT ID: NCT02660684 Org: User:
Start: 02/29/08 End: 02/28/10 Due: 02/28/11

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04691648 Org: User:
Start: 06/17/22 End: 05/04/25 Due: 05/04/26

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Phase: N/A Priority: Normal
NCT ID: NCT02452632 Org: User:
Start: 06/22/15 End: 01/05/17 Due: 01/05/18

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01763580 Org: User:
Start: 07/16/12 End: 08/21/17 Due: 08/21/18

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT03737708 Org: User:
Start: 02/13/19 End: 06/16/20 Due: 06/16/21

A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01742676 Org: User:
Start: 04/30/11 End: 04/30/13 Due: 04/30/14

A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT03118713 Org: User:
Start: 04/25/17 End: 12/12/18 Due: 12/12/19